Arvinas, Inc. (ARVN) Financials
ARVN Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 1.3 billion | 644.6 million |
2023-09-30 | 1.1 billion | 601.1 million |
2023-06-30 | 1.1 billion | 619.9 million |
2023-03-31 | 1.2 billion | 664.8 million |
ARVN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -83.2 million | 16.7 million |
2023-09-30 | -85.9 million | 16.7 million |
2023-06-30 | -89.3 million | 18.3 million |
2023-03-31 | -92.3 million | 19.9 million |
ARVN Net Income
No data available :(
ARVN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 1.3 billion | - | 2.4 million |
2023-09-30 | 998.5 million | - | 3.0 million |
2023-06-30 | 1.0 billion | 900000 | 3.5 million |
2023-03-31 | 1.1 billion | 900000 | 4.0 million |
ARVN Shares Outstanding
ARVN Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 100000 | 95.2 million | 27.0 million | 1.7 million |
2023-09-30 | 1.1 million | 85.9 million | 22.6 million | - |
2023-06-30 | 600000 | 103.4 million | 25.7 million | - |
2023-03-31 | 1.1 million | 95.3 million | 24.9 million | - |
ARVN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | -43.1 million | 1.7 million |
2023-09-30 | 34.6 million | 1.7 million |
2023-06-30 | 54.5 million | 1.6 million |
2023-03-31 | 32.5 million | 1.7 million |
ARVN
Price: $32.43
52 week price:
Earnings Per Share: -6.62 USD
P/E Ratio: -9.50
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 476209
Market Capitalization: 2.3 billion